Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells. 2008

Yong Xia, and Chuan-Dong Fan, and Bao-Xiang Zhao, and Jing Zhao, and Dong-Soo Shin, and Jun-Ying Miao
Institute of Organic Chemistry, School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, China.

A series of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives were synthesized and the effects of all the compounds on A549 cell growth were investigated. The results showed that all compounds had almost inhibitory effects on the growth of A549 cells. The study on structure-activity relationships and prediction of lipophilicities of compounds showed that compounds with LogP values in the range of 4.12-6.80 had inhibitory effects on the growth of A549 cells, and among of them the hydrazone derived from salicylaldehyde had much more inhibitory effects.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Yong Xia, and Chuan-Dong Fan, and Bao-Xiang Zhao, and Jing Zhao, and Dong-Soo Shin, and Jun-Ying Miao
November 2007, Bioorganic & medicinal chemistry,
Yong Xia, and Chuan-Dong Fan, and Bao-Xiang Zhao, and Jing Zhao, and Dong-Soo Shin, and Jun-Ying Miao
July 2008, Bioorganic & medicinal chemistry letters,
Yong Xia, and Chuan-Dong Fan, and Bao-Xiang Zhao, and Jing Zhao, and Dong-Soo Shin, and Jun-Ying Miao
March 2009, Bioorganic & medicinal chemistry,
Yong Xia, and Chuan-Dong Fan, and Bao-Xiang Zhao, and Jing Zhao, and Dong-Soo Shin, and Jun-Ying Miao
December 2011, European journal of medicinal chemistry,
Yong Xia, and Chuan-Dong Fan, and Bao-Xiang Zhao, and Jing Zhao, and Dong-Soo Shin, and Jun-Ying Miao
February 2017, Molecular and cellular biochemistry,
Yong Xia, and Chuan-Dong Fan, and Bao-Xiang Zhao, and Jing Zhao, and Dong-Soo Shin, and Jun-Ying Miao
July 2010, Bioorganic & medicinal chemistry,
Yong Xia, and Chuan-Dong Fan, and Bao-Xiang Zhao, and Jing Zhao, and Dong-Soo Shin, and Jun-Ying Miao
July 2009, Carbohydrate research,
Yong Xia, and Chuan-Dong Fan, and Bao-Xiang Zhao, and Jing Zhao, and Dong-Soo Shin, and Jun-Ying Miao
October 2009, Bioorganic & medicinal chemistry,
Yong Xia, and Chuan-Dong Fan, and Bao-Xiang Zhao, and Jing Zhao, and Dong-Soo Shin, and Jun-Ying Miao
January 2013, PloS one,
Yong Xia, and Chuan-Dong Fan, and Bao-Xiang Zhao, and Jing Zhao, and Dong-Soo Shin, and Jun-Ying Miao
October 2003, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!